A comparative study of Arogyavardhini Vati orally with Manjishtha Lepa locally and Manjishtha Lepa only in the management of Vyanga

Add on effect of Arogyavardhini vati along with Manjishtha Lepa in comparison with Manjishtha Lepa only in the management of vyanga with special reference to Melasma: A Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088126

Enrollment

Registered

2025-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age group between 30 to 50 years. Patient of either gender, irrespective of socioeconomic status. Patients not using any topical treatment for melasma prior to enrollement in study.

Exclusion criteria

Exclusion criteria: Patients taking Oral Contraceptive Pills or injected depot formation. Patients suffering from other skin disorder. Patients having chronicity of more than 3 years. History of Allergy to tropical application. Cancer of skin. Any hyper pigmentation due to chemical exposure, burn wounds and drug induced.

Design outcomes

Primary

Measure	Time frame
To study the add on effect of Arogyavardhini Vati and local application of Manjishtha Lepa in the management of Vyanga.Timepoint: At the end of 4 weeks	—

Secondary

Measure	Time frame
To find better treatment for Vyanga.Timepoint: At the end of 28 days	—

Countries

India

Contacts

Public ContactVD ARCHANA S DACHEWAR

Shri Ayurveda Mahavidyalaya, Nagpur

dr.dachewar@gmail.com9822206312

Outcome results